1st Counsel – Lifestyle
Author:
NovaBridge Biosciences
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
April 22, 2026
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update
April 8, 2026
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
March 16, 2026
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
March 9, 2026